Prednisolone reduces the interferon response to AAV in cynomolgus macaques and may increase liver gene expression - ScienceDirect
Frontiers | IFN-γ, should not be ignored in SLE
IJMS | Free Full-Text | The Pathogenesis, Molecular Mechanisms, and Therapeutic Potential of the Interferon Pathway in Systemic Lupus Erythematosus and Other Autoimmune Diseases
JCI - IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
The baseline interferon signature predicts disease severity over the subsequent 5 years in systemic lupus erythematosus | Arthritis Research & Therapy | Full Text
a) Heatmap displaying associations of cell populations with interferon... | Download Scientific Diagram
An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer | PNAS
Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus | PNAS
Overexpression of type I interferon (IFN) inducible genes as captured... | Download Scientific Diagram
Frontiers | Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling Pathways
An Interferon Response Gene Signature Is Associated with the Therapeutic Response of Hepatitis C Patients | PLOS ONE
Gene expression analysis delineates the potential roles of multiple interferons in systemic lupus erythematosus | Communications Biology
a) Boxplots displaying correlation between interferon gene signature... | Download Scientific Diagram
Interferon target-gene expression and epigenomic signatures in health and disease | Nature Immunology
Type I interferon gene signature test–low and –high patients with systemic lupus erythematosus have distinct gene expression signatures - PZ Brohawn, K Streicher, B W Higgs, C Morehouse, H Liu, G Illei,
Molecular characterization of type I IFN-induced cytotoxicity in bladder cancer cells reveals biomarkers of resistance: Molecular Therapy - Oncolytics
Expression characteristics of interferon-stimulated genes and possible regulatory mechanisms in lupus patients using transcriptomics analyses - eBioMedicine
Higher interferon score and normal complement levels may identify a distinct clinical subset in children with systemic lupus erythematosus | Arthritis Research & Therapy | Full Text
Interferon target-gene expression and epigenomic signatures in health and disease | Nature Immunology
Interferon pathway in SLE: one key to unlocking the mystery of the disease | Lupus Science & Medicine
How cancer cells make and respond to interferon-I: Trends in Cancer
Frontiers | Type I Interferon Signature in Primary Antiphospholipid Syndrome: Clinical and Laboratory Associations
Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19 - ScienceDirect
Association of the interferon signature metric with serological disease manifestations but not global activity scores in multiple cohorts of patients with SLE | Lupus Science & Medicine
Pharmacokinetics, pharmacodynamics, and safety of subcutaneous anifrolumab in patients with systemic lupus erythematosus, active skin disease, and high type I interferon gene signature: a multicentre, randomised, double-blind, placebo-controlled, phase ...
Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus | PNAS
